BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 2908715)

  • 1. Hemodynamic responses to different levels of alpha-adrenergic interruption in congestive heart failure.
    Good AP; Unverferth DV; Leier CV
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):529-34. PubMed ID: 2908715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of pharmacodynamic tolerance to prozosin in congestive heart failure.
    Desch CE; Magorien RD; Triffon DW; Blanford MF; Unverferth DV; Leier CV
    Am J Cardiol; 1979 Nov; 44(6):1178-82. PubMed ID: 495512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow.
    Leier CV; Patrick TJ; Hermiller J; Pacht KD; Huss P; Magorien RD; Unverferth DV
    Am Heart J; 1984 Dec; 108(6):1461-8. PubMed ID: 6507242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic responses to indoramin at rest and during exercise in congestive heart failure.
    Leier CV; Majetich N; Binkley PF; Uverferth DV
    Pharmacotherapy; 1987; 7(3):61-8. PubMed ID: 3628063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute hemodynamic and hormonal effects of central versus peripheral sympathetic inhibition in patients with congestive heart failure.
    Olivari MT; Levine TB; Cohn JN
    J Cardiovasc Pharmacol; 1986; 8(5):973-7. PubMed ID: 2429099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indoramin in severe congestive heart failure.
    Grube E; Manz M; Lüderitz B
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S117-23. PubMed ID: 2423784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
    Magorien RD; Triffon DW; Desch CE; Bay WH; Unverferth DV; Leier CV
    Ann Intern Med; 1981 Jul; 95(1):5-13. PubMed ID: 7247126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute hemodynamic and hormonal response to indoramin in congestive heart failure.
    Olivari MT; Garberg VR; Selby T; Cohn JN; Levine TB
    Clin Pharmacol Ther; 1984 Sep; 36(3):297-301. PubMed ID: 6380878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional hemodynamic effects of clonidine in congestive heart failure.
    Magorien RD; Hermiller JB; Unverferth DV; Leier CV
    J Cardiovasc Pharmacol; 1985; 7(1):91-6. PubMed ID: 2580157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary observations of chronic indoramin therapy in congestive heart failure.
    Leier CV; Huss P; Parrish D; Binkley PF; Unverferth DV
    J Cardiovasc Pharmacol; 1986; 8 Suppl 2():S112-6. PubMed ID: 2423783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in the effects of alpha-1 adrenergic blockade with prazosin and indoramin on coronary blood flow during exercise.
    Bache RJ; Homans DC; Schwartz JS; Dai XZ
    J Pharmacol Exp Ther; 1988 Apr; 245(1):232-7. PubMed ID: 2896237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of terazosin in congestive heart failure.
    Zhu J; Wang D; Lu Z; Liu Z; Yang D
    Chin Med Sci J; 1993 Jun; 8(2):98-100. PubMed ID: 7904837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute hemodynamic effects of nitrendipine in chronic congestive heart failure.
    Olivari MT; Levine TB; Cohn JN
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1002-5. PubMed ID: 6085356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of prazosin effect on cardiac output in chronic heart failure.
    Arnold SB; Williams RL; Ports TA; Baughman RA; Benet LZ; Parmley WW; Chatterjee K
    Ann Intern Med; 1979 Sep; 91(3):345-9. PubMed ID: 475164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alpha receptor blocking and cardial insufficiency].
    Klein W
    Wien Med Wochenschr; 1982; 132 Spec No():6-9. PubMed ID: 6123199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between drug-induced changes in central and regional hemodynamics in congestive heart failure.
    Cotsamire DL; Unverferth DV; Leier CV
    Can J Cardiol; 1986; 2(5):272-7. PubMed ID: 3768787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hemodynamic and clinical responses to terazosin, a new alpha blocking agent, in congestive heart failure.
    Leier CV; Patterson SE; Huss P; Parrish D; Unverferth DV
    Am J Med Sci; 1986 Sep; 292(3):128-35. PubMed ID: 2875651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indoramin in heart failure: possible adverse effects on hemodynamics and exercise capacity.
    Seth L; Galiè N; Casebolt P; Gimenez H; Malloy M; Franciosa JA
    Clin Pharmacol Ther; 1986 Nov; 40(5):567-74. PubMed ID: 3769387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac and systemic sympathetic activity in response to clonidine in human heart failure.
    Azevedo ER; Newton GE; Parker JD
    J Am Coll Cardiol; 1999 Jan; 33(1):186-91. PubMed ID: 9935028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prostacyclin and prazosin in the treatment of congestive heart failure; with special reference to the sympathetic nervous system.
    Yui Y; Sakurai T; Nakajima H; Kawai C
    Jpn Circ J; 1984 Apr; 48(4):365-72. PubMed ID: 6371282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.